share_log

HC Wainwright & Co. Maintains Buy on LAVA Therapeutics, Lowers Price Target to $2

HC Wainwright & Co. Maintains Buy on LAVA Therapeutics, Lowers Price Target to $2

HC Wainwright & Co. 维持对LAVA Therapeutics的买入评级,将目标价格下调至2美元
Benzinga ·  2024/12/20 20:15  · 评级/大行评级

HC Wainwright & Co. analyst Arthur He maintains LAVA Therapeutics (NASDAQ:LVTX) with a Buy and lowers the price target from $6 to $2.

HC Wainwright & Co. 分析师Arthur He维持LAVA Therapeutics(纳斯达克: LVTX)的买入评级,并将目标价从6美元下调至2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发